Carlsmed, Inc. CARL
NASDAQ
| 09/30/2026 | 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | |
|---|---|---|---|---|---|
| Revenue | 21.55M | 18.94M | 16.12M | 15.17M | 13.07M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 21.55M | 18.94M | 16.12M | 15.17M | 13.07M |
| Cost of Revenue | 4.89M | 4.40M | 3.69M | 3.56M | 3.15M |
| Gross Profit | 16.67M | 14.54M | 12.43M | 11.61M | 9.93M |
| SG&A Expenses | 22.99M | 19.54M | 16.52M | 15.66M | 14.52M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 34.26M | 29.98M | 25.39M | 24.48M | 22.11M |
| Operating Income | -12.70M | -11.04M | -9.28M | -9.32M | -9.04M |
| Income Before Tax | -12.25M | -10.51M | -8.70M | -8.61M | -8.53M |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -12.25M | -10.51M | -8.70M | -8.61M | -8.53M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -12.25M | -10.51M | -8.70M | -8.61M | -8.53M |
| EBIT | -12.70M | -11.04M | -9.28M | -9.32M | -9.04M |
| EBITDA | -12.58M | -10.91M | -9.18M | -9.22M | -8.95M |
| EPS Basic | -0.45 | -0.39 | -0.32 | -0.32 | -0.40 |
| Normalized Basic EPS | -0.28 | -0.24 | -0.20 | -0.20 | -0.25 |
| EPS Diluted | -0.45 | -0.39 | -0.32 | -0.32 | -0.40 |
| Normalized Diluted EPS | -0.28 | -0.24 | -0.20 | -0.20 | -0.25 |
| Average Basic Shares Outstanding | 27.30M | 27.19M | 26.84M | 26.60M | 21.08M |
| Average Diluted Shares Outstanding | 27.30M | 27.19M | 26.84M | 26.60M | 21.08M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |